Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
114.9 USD | -2.74% | -6.24% | -20.45% |
Jun. 07 | Chile's Codelco targeting 2030 production for Maricunga lithium site, document shows | RE |
Jun. 06 | Chile's Codelco targeting 2030 production for Maricunga lithium site, document shows | RE |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The group shows a rather high level of debt in proportion to its EBITDA.
- With a 2024 P/E ratio at 40.7 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-20.45% | 13.51B | C+ | ||
+20.59% | 68.31B | A- | ||
-1.39% | 48.49B | A- | ||
+32.00% | 28.29B | A- | ||
+7.64% | 19.12B | C+ | ||
+10.55% | 16.64B | B+ | ||
-5.73% | 16B | B+ | ||
-21.45% | 15.84B | A- | ||
-24.56% | 12.98B | A- | ||
+16.11% | 11.03B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ALB Stock
- Ratings Albemarle Corporation